MEHLMAN CONSULTING, INC. for MAYO CLINIC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
NIH appropriations. Clinical laboratory reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| SOHINI GUPTA | — |
| BRUCE MEHLMAN | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Medicare/Medicaid MMM
Quality payments for providers. Accountable care organizations. Clinical laboratory reimbursement. Physician payment policies. S. Con Res 11 and H. Con Res 27, Establishing the budget for the U.S. government for FY2016. H.R. 2, The Medicare Access and CHIP Reauthorization Act of 2015.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| SOHINI GUPTA | — |
| BRUCE MEHLMAN | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Health Issues HCR
General healthcare. General health reform implementation. Healthcare value and quality. ICD-10 implementation. Health information technology, clinical trials, telehealth. Precision medicine, delivery system reform. S. Con Res 11 and H. Con Res 27, Establishing the budget for the U.S. government for FY2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| DAVID CASTAGNETTI | — |
| SAGE EASTMAN | — |
| ELISE FINLEY PICKERING | — |
| SOHINI GUPTA | — |
| BRUCE MEHLMAN | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| CHARLES WOOTERS | — |
| SUSAN ZOOK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.